Mr. Speaker, I would again remind the NDP opposition that it should not prejudge the outcome of these negotiations.
Our government has always sought to find a balance between protecting our innovators in Canada while, at the same time, ensuring that Canadians have affordable drugs available to them. We continue to consult with the provinces on this issue and we will continue to do so. At the end of the day, we will only sign an agreement that is in the best interests of Canadians.